loader image
Sunday, February 23, 2025
46.3 F
McAllen
We Welcome your Press Release
- Advertisement -

Health providers have an opportunity to further their education

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

If you are a healthcare provider and want to understand how managed care operates within the South Texas Market, this is a must-attend lunch & learn workshop presented by the experts in the field.

Please register at your earliest convenience to take advantage of this unique opportunity.

The Evolving Healthcare Market in South Texas

- Advertisement -

Course Objectives:

§  Understand current evolution of South Texas Healthcare market place

§  Quality initiatives undertaken by Managed Care Organization (MCOs)

§  Pay for Performance concept and how it affects healthcare practice.

- Advertisement -

§  Become familiar with the Medicaid and its future evolution

·         Become prepared to adapt and thrive within a managed care market place

The Evolving Healthcare Market in South Texas – Managed Care and Its Influence in Quality of Care Outcomes

Summary

This workshop will provide a basic understanding of the fundamentals of how managed care operates within the South Texas Market and how through the implementation of quality based initiatives, it strives to affect positive outcomes in the populations served. The participants will be able to gain insight to future market trends that will include compensation models based on quality outcomes.

Course Objectives:

  • Understand current evolution of South Texas Healthcare market place
  • Quality initiatives undertaken by Managed Care Organization (MCOs)
  • Pay for Performance concept and how it affects healthcare practice.
  • Become familiar with the Medicaid and its future evolution
  • Become prepared to adapt and thrive within a managed care market place

Course Date

September 10th, 2014 from 11:30 a.m.– 1 p.m.

Who Should Attend?

  • Physicians & mid-level practitioners.
  • Practice Managers
  • Rehab Facilities.
  • Ancillary Providers.
  • Home Health and Hospice providers.
  • DMEs’.
  • Any medicare or medicaid provider.

Are You Ready for a Visit from the OIG? (Office of Inspector General)

Summary

This course will provide a basic understanding of the fundamentals of a health care compliance program and the penalties for not having one in place. The participants will become familiar with various governmental agencies, contractors involved in enforcement and recent levied penalties.

Course Objectives:

  • Understand how a health care compliance program works.
  • Learn about consequences of Non-compliance.
  • Become familiar with enforcement entities, the scope of their authority and how to manage their visits.

Course Date

May 8th, 2014 from 12:00 pm – 1:30 pm

Who Should Attend?

  • Physicians.
  • Dentists.
  • DMEs’.
  • Rehab Facilities.
  • Ancillary Providers.
  • Home Health and Hospice providers.
  • Any medicare or medicaid provider.
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
Ă—